Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.
about
Nedocromil sodium for chronic asthma in childrenA novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulationGenome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response genePredicting response to short-acting bronchodilator medication using Bayesian networks.In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidaForced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values.Exhaled nitric oxide and clinical phenotypes of childhood asthma.The IgE response to Ascaris molecular components is associated with clinical indicators of asthma severity.The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometryAssessment of bronchodilator responsiveness after methacholine-induced bronchoconstrictionGenome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.Stress and Bronchodilator Response in Children with Asthma.Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity.Effect of vitamin D and inhaled corticosteroid treatment on lung function in childrenThe Childhood Asthma Management Program (CAMP): Contributions to the Understanding of Therapy and the Natural History of Childhood AsthmaDevelopment of a Pharmacogenetic Predictive Test in asthma: proof of concept.Association of FEF25%-75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma.Diagnostic accuracy of the bronchodilator response in children.Predictors of response to tiotropium versus salmeterol in asthmatic adults.Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma.Evaluation of monitoring strategies for childhood asthma.Bronchodilator responsiveness in wheezy infants predicts continued early childhood respiratory morbidity.The bronchodilator response as a predictor of inhaled corticosteroid responsiveness in asthmatic children with normal baseline spirometry.Obstruction phenotype as a predictor of asthma severity and instability in children.Steroid Pathway Genes and Neonatal Respiratory Distress After Betamethasone Use in Anticipated Preterm Birth.Exercise-induced bronchospasm diagnosis in children. Utility of combined lung function tests.Gut microbiota components are associated with fixed airway obstruction in asthmatic patients living in the tropics.
P2860
Q24244890-E35122FD-BDCA-4033-BBA3-4980D413C23CQ28258154-64C50F0B-EAE7-4719-920A-FEE00D383CAAQ28481005-056C0803-2FBA-45DC-A072-E344CB27DAFEQ33581533-39268C55-9F56-435E-8C87-DD2658690E0CQ33804636-EA70A754-0CD4-4377-AB14-AAF1BB41E216Q34106509-7080B2E3-C449-402A-BE68-2EC9134B7666Q35078159-B493B698-7796-4E0E-A5FA-DFE9A378511DQ35141876-611505DA-5342-4F34-9EAC-17B9699A3EFEQ35178572-C1FF57EC-6459-4B21-9FB7-0A9A0D5F7C00Q35228571-F258547E-9939-4463-A848-92ABD7D00F53Q35261929-300FD039-EFDB-4B42-8AC9-0E5C8EBE1BB3Q35879689-2B9D4F9E-39F0-4502-A728-CDCEFAB49656Q35886051-88C3F9BE-96CD-427D-8EA9-3CAAD4FB6B37Q36098864-2FA8D30B-929B-4899-BE78-48E5027A5E80Q36345285-02407285-C658-4695-9B72-67D29B262F8FQ36538896-B0C289AA-FAEF-49DE-9C0E-FA7B03F13DC3Q36845596-1F69B4FA-A7CF-44A4-8E9E-7FA39A360905Q37060245-843C93C0-E043-44B5-AE5C-41D8A35B9EA5Q37138169-44946A1A-AE92-47DB-BF17-E422FB9A5C13Q37303840-06C8749A-F617-49E2-ADEB-D6C3EB8BA9E8Q38805229-53978620-B408-4748-845F-371DC70AD438Q38963960-95A37AF0-AB6A-4611-8A59-C99E71A211CCQ39865807-6782EDDC-1390-4325-98B3-4AFC5682D280Q46762324-6025B70E-D159-4A1E-A814-71438DCA5559Q47583247-9DD173FB-3C1B-40EC-95A9-ACBCFA4B048AQ51579824-340A0F5C-EFAB-447E-A0E6-1070325F008DQ51680198-DC6BBE80-505D-452B-8105-EC656E7ED166Q55428575-9A265FEF-3B1C-442C-8079-82749C36D056
P2860
Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical predictors and outcom ...... ood asthma management program.
@ast
Clinical predictors and outcom ...... ood asthma management program.
@en
Clinical predictors and outcom ...... ood asthma management program.
@nl
type
label
Clinical predictors and outcom ...... ood asthma management program.
@ast
Clinical predictors and outcom ...... ood asthma management program.
@en
Clinical predictors and outcom ...... ood asthma management program.
@nl
prefLabel
Clinical predictors and outcom ...... ood asthma management program.
@ast
Clinical predictors and outcom ...... ood asthma management program.
@en
Clinical predictors and outcom ...... ood asthma management program.
@nl
P2093
P2860
P1476
Clinical predictors and outcom ...... ood asthma management program.
@en
P2093
Amy J Murphy
Anne L Fuhlbrigge
Childhood Asthma Management Program Research Group
Kelan G Tantisira
Robert C Strunk
Robert S Zeiger
Scott T Weiss
Sunita Sharma
P2860
P304
921-928.e4
P356
10.1016/J.JACI.2008.09.004
P407
P577
2008-10-10T00:00:00Z